Scientists hunt for genetic markers in ovarian, uterine, and cervical cancers

NCT ID NCT01977274

Ongoing Knowledge-focused Sponsor: Institut Paoli-Calmettes Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting blood and tumor samples from 300 people suspected of having ovarian, endometrial, or cervical cancer. Researchers will analyze the samples to find genetic changes that might predict how the cancer behaves. The goal is to better understand these cancers, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict how gynecological cancers will behave and possibly guide future treatments.
What could go wrong: This is an observational study, not a treatment trial. It is not designed to test a therapy, so any benefits are indirect and may take years to realize.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVIX CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical carcinoma endometrial cancer endometrium neoplasm ovarian cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVIX CANCER ENDOMETRIUM CANCER OVARIAN CANCER

Contacts and locations

Locations

Institut Paoli Calmettes

Marseille, 13 009, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.